Gujarat Kidney & Super Speciality IPO Subscription Day 1

Here, the Gujarat Kidney & Super Speciality IPO launched on 22nd December 2025. Bidding for the issue will close today, 30th December 2025. The primary aim of the Gujarat Kidney & Super Speciality IPO is to raise ₹250.80 crores from the market. Also, the Gujarat Kidney & Super Speciality IPO has received an impressive level of subscription, indicating that the shares will be listed at an impeccable premium. Scroll down to check the Gujarat Kidney & Super Speciality IPO subscription and details. 

Gujarat Kidney & Super Speciality IPO Details 

The price band for Riddhi Display Equipment’s IPO has been set at ₹108 to ₹114 per share, and a total of 2,20,00,000 shares are being issued. Let’s segregate the share quota fixed for different categories of investors. 

Gujarat Kidney & Super Speciality IPO Subscription Status

As of now, the Gujarat Kidney & Super Speciality IPO has been subscribed to 1.54 times. Of these, 5.07 times are subscribed by retail investors, 1.98 times by non-institutional investors, and 0.34 times by QII (Qualified Institutional Investors).  

The healthy subscription status indicates that investors are expecting higher returns at the time of Gujarat Kidney & Super Speciality’ IPO listing on 30th December 2025. Gujarat Kidney & Super Speciality also has a positive outlook behind the fresh issue of 2.20 crore shares, which will raise around Rs 250.80 crores.

Gujarat Kidney & Super Speciality IPO GMP Today

We know that higher subscription levels drive grey-market premiums for IPOs. Let’s explore the Gujarat Kidney & Super Speciality IPO GMP for 22nd December 2025. 

The grey market premium for this IPO has surged to 2.63% or Rs 3.00 per share. It indicates that the estimated listing price per share is Rs 117.00. Numerous factors played a pivotal role in this jump in the GMP of Riddhi Display Equipment’s IPO. These include higher subscription rates, favourable market sentiment, and investors’ positive attitude towards IPOs. 

About Gujarat Kidney & Super Speciality Ltd.

Gujarat Kidney & Super Speciality was established in 2019. Gujarat Kidney and Super Speciality Limited (GKASSL) specialises in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India. The company operates seven multispeciality hospitals and four pharmacies, with a total bed capacity of 490, an approved capacity of 455, and an operational capacity of 340. The company’s hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand).

Gujarat Kidney & Super Speciality Limited Financials

The company’s financial analysis is essential before applying for the Gujarat Kidney & Super Speciality IPO. Look at the table to learn about Gujarat Kidney & Super Speciality Limited’s financials. 

Explanation

Gujarat Kidney & Super Speciality Limited’s revenue increased by 637% from ₹5.48 crores in March 2024  to ₹40.40 crores in March 2025. Moreover, the company’s PAT increased by 454% from ₹1.71 crores in March 2024 to ₹9.50 crores in March 2025.

Technical Indicators

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Gujarat Kidney & Super Speciality IPO.

Gujarat Kidney & Super Speciality IPO Listing Expectations

Gujarat Kidney & Super Speciality IPO Highlights: IPO allotment is still pending, as the bid will close today. However, given the current GMP or market sentiment, it is reasonable to expect higher listing gains for the share. A jump of 2.63% in Yash Highlight GMP suggests the estimated listing price per share will be around Rs 117.

It will provide higher listing gains to investors who applied for this IPO. Also, the financial fundamentals of this business made it the experts’ top long-term recommendation. 

Gujarat Kidney & Super Speciality IPO Dates

Note: IPO GMP is volatile and depends on market sentiment. Hence, one should conduct their research before investing in it.

Recent Articles

Icodex Publishing Solutions IPO GMP: Day 1 IPO Live Updates

Bluestone Jewellery IPO GMP: Day 1 IPO Live Updates

Highway Infrastructure IPO Listing Preview: What to Expect Now in 2025?

Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to ₹44.06 Crore; Revenue Down 5.47% YoY

Action Construction Equipment Q1 Results FY26: Q1 PAT Rises 16.08% to ₹97.72 Crore; Revenue Down 11.19% YoY

Sawaliya Foods Products IPO Allotment Status Check Online: GMP, Subscription, Price, and More

Gujarat Kidney & Super Speciality IPO Allotment Status Check Online: GMP, Subscription, Price, and More

Mahendra Realtors IPO GMP & Review: Apply or Avoid?

Regaal Resources IPO GMP & Review: Apply or Avoid?

Icodex Publishing Solutions IPO GMP & Review: Apply or Avoid?